Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

As of this month, about 37 percent of adults 18 and older had received a seasonal flu shot, while 19 percent had received ...

The goal is to "create a vaccine that prevents the most severe disease manifestations that result in hospitalization or death ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

RSV is the most common cause of hospitalization in infants under 1 year old. The infection can spread to the lungs and cause ...

Previously the hospital offered the clinic to those born on or after January 1, 2024, without a primary care practitioner.

A new Centers for Disease Control and Prevention (CDC) report reveals low uptake of flu, COVID-19 and respiratory syncytial ...

Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness,” published in the November 2024 issue ...

It's recommended that everyone 75 and older should get the RSV vaccine. Everyone 60 and older with a chronic condition may be ...

Some hospitals in the U.S. are seeing an increase in cases of RSV and so-called "walking pneumonia." Here's what you need to ...

FluMist, a self-administered flu vaccine, is approved for ages 2-49, but will be available in the 2025-2026 season. RSV vaccination is vital for older adults, with new guidelines for those aged 60-74, ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have ...